• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Revolutionizing Rheumatology | Remission & Sentara’s Dynamic Partnership

Share:

March 26, 2024

Remission Medical and Sentara Health join forces to enhance rheumatology care access. Leveraging telehealth solutions, patients can receive virtual triage and care coordination alongside in-person appointments with Sentara rheumatologists. This collaboration embodies a commitment to improving health outcomes and streamlining the care pathway for individuals with rheumatic conditions.

In a monumental move aimed at revolutionizing rheumatology care, Remission Medical has proudly announced its partnership with Sentara Health, a healthcare giant dedicated to improving health outcomes for over a century. This groundbreaking collaboration seeks to address the pressing need for enhanced access to rheumatological expertise among adult patients, leveraging innovative telehealth solutions and streamlined processes to ensure swift diagnosis and treatment.

For over 130 years, Sentara Health has remained steadfast in its mission to “improve health every day.” Central to this mission is the unwavering commitment to providing patients with seamless access to specialized care, facilitated by cutting-edge technologies and a patient-centric approach. Recognizing the significance of timely intervention in rheumatic conditions, Sentara Health has embraced telehealth as a pivotal tool in expanding access to rheumatology services, including video visits for maximum convenience and efficiency.

Rheumatic conditions, encompassing a spectrum of disorders such as arthritis, pose a significant health burden, affecting approximately one in four adults in the United States, according to the Centers for Disease Control and Prevention (CDC). Characterized by symptoms like joint pain and stiffness, these conditions can severely impact individuals’ quality of life, impairing their ability to perform everyday tasks and engage in meaningful activities. Moreover, the complexity and diversity of rheumatic diseases present challenges in diagnosis and treatment, with over 150 distinct varieties complicating the clinical landscape.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Dr. Steven Pearman, Vice President and Chief Medical Officer of Medical Specialties at Sentara Health, emphasizes the critical importance of timely diagnosis and intervention in rheumatology, particularly for conditions like rheumatoid arthritis. “The medical literature underscores the significance of early treatment initiation in mitigating joint damage associated with rheumatic diseases,” states Dr. Pearman. “Given the escalating demand for rheumatology services coupled with a shortage of specialists, rapid access to care is imperative. Telehealth emerges as a valuable tool for facilitating expedited triage and ensuring timely intervention.”

Sentara Health’s longstanding commitment to telehealth innovation has positioned the organization as a trailblazer in virtual care delivery. Since forging an alliance with MDLIVE (now Cigna) in 2012, Sentara Health has remained at the forefront of integrated health systems offering virtual access to healthcare services. Building upon this foundation, Sentara Health is poised to expand its telehealth capabilities to include virtual rheumatology appointments, catering to patients experiencing the onset of rheumatic symptoms.

Blake Wehman, Founder & CEO of Remission Medical, lauds Sentara Health’s track record of innovation and patient-centered care. “As a Virginia-based company, we’ve witnessed firsthand Sentara’s commitment to advancing patient access, digital health, and value-based care,” remarks Wehman. “We are honored to collaborate with Sentara providers in ensuring that patients with rheumatic conditions receive prompt and accurate diagnosis and treatment.”

The collaborative partnership between Remission Medical and Sentara Health holds immense promise for revolutionizing rheumatology care delivery. By harnessing the power of telehealth technologies, patients experiencing the onset of rheumatic symptoms can benefit from virtual triage and care coordination, complementing in-person consultations with Sentara rheumatologists. This integrated approach not only streamlines the care pathway but also empowers patients with greater control over their health journey.

In conclusion, the alliance between Remission Medical and Sentara Health marks a significant milestone in advancing rheumatology care accessibility and efficiency. By leveraging telehealth solutions and fostering collaboration between healthcare stakeholders, this partnership epitomizes the commitment to improving health outcomes and enhancing patient experiences. As the healthcare landscape continues to evolve, initiatives like these serve as beacons of innovation, driving positive change and transforming the delivery of specialized care.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AbbVie Patent Deal Staves Off Amgen Competition, But Others LurkAbbVie Patent Deal Staves Off Amgen Competition, But Others Lurk
  • Hologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery FranchiseHologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery Franchise
  • Everlywell Forms New At-home Lab Testing Subsidiary Through PWNHealth PurchaseEverlywell Forms New At-home Lab Testing Subsidiary Through PWNHealth Purchase
  • Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-MarketKintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market
  • Nordic Consulting Acquires Healthcare Consulting Firm HygeianNordic Consulting Acquires Healthcare Consulting Firm Hygeian
  • Lilly Completes Acquisition of Versanis BioLilly Completes Acquisition of Versanis Bio
  • Covid-19 Vaccines, Tests and Treatments Spur Healthcare M&ACovid-19 Vaccines, Tests and Treatments Spur Healthcare M&A
  • Avidity Science Acquires Edstrom Japan LtdAvidity Science Acquires Edstrom Japan Ltd

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications